Early Tracking after a Missed Return Visit Reduces the Proportion of Untraceable Patients at a Large HIV Clinic in Kampala, Uganda

To determine the optimal time to track patients, we evaluated the outcomes of patients traced after missing their return visits at 3 periods, 8, 30, or 90 days, at the Infectious Diseases Clinic in Kampala, Uganda. During the study period from January to December 2011, the proportion of untraceable patients was 2 (4%) after 8 days, 12 (10%) after 30 days, and 13 (15%) after 90 days. More than 75% of the patients who died had a CD4 count of <200 cells/mm3 at their last visit. In conclusion, tracking patients after 1 week of a missed return visit should be the preferred method of tracking. If resources are limited, patients with CD4 counts <200 cells/mm3 need to be targeted for tracking, as they are most at risk of dying if they interrupt treatment.

[1]  E. Katabira,et al.  A Pharmacy-Only Refill Program at a Large HIV Clinic in Uganda , 2014, Journal of the International Association of Providers of AIDS Care.

[2]  E. Katabira,et al.  Factors before enrolment are associated with being removed from a Pharmacy-only Refill Programme at a large urban HIV/AIDS clinic, Uganda , 2014, International journal of STD & AIDS.

[3]  M. Wubshet,et al.  Death and Seeking Alternative Therapy Largely Accounted for Lost to Follow-up of Patients on ART in Northwest Ethiopia: A Community Tracking Survey , 2013, PloS one.

[4]  D. Cameron,et al.  Recall of lost-to-follow-up pre-antiretroviral therapy patients in the Eastern Cape: effect of mentoring on patient care. , 2012, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[5]  F. Wabwire-mangen,et al.  Return to Normal Life After AIDS as a Reason for Lost to Follow-up in a Community-Based Antiretroviral Treatment Program , 2012, Journal of acquired immune deficiency syndromes.

[6]  Glenn J. Wagner,et al.  Electronic Medical Records and Same Day Patient Tracing Improves Clinic Efficiency and Adherence to Appointments in a Community Based HIV/AIDS Care Program, in Uganda , 2012, AIDS and Behavior.

[7]  T. Reid,et al.  Implementation and outcomes of an active defaulter tracing system for HIV, prevention of mother to child transmission of HIV (PMTCT), and TB patients in Kibera, Nairobi, Kenya. , 2011, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  H. Tweya,et al.  Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi , 2011, BMC infectious diseases.

[9]  Nneka Emenyonu,et al.  Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach , 2010, Journal of acquired immune deficiency syndromes.

[10]  M. Egger,et al.  Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis , 2009, PloS one.

[11]  C. Yiannoutsos,et al.  Sampling-Based Approaches to Improve Estimation of Mortality among Patient Dropouts: Experience from a Large PEPFAR-Funded Program in Western Kenya , 2008, PloS one.

[12]  B. Chi,et al.  Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia , 2008, AIDS care.

[13]  T. Quinn,et al.  Predictors of Long-Term Viral Failure Among Ugandan Children and Adults Treated With Antiretroviral Therapy , 2007, Journal of acquired immune deficiency syndromes.

[14]  Sydney Rosen,et al.  Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review , 2007, PLoS medicine.

[15]  E. Schouten,et al.  True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. , 2007, Bulletin of the World Health Organization.

[16]  J. Sterne,et al.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.